- Home
- DGX vs DXCM Comparison
DGX vs DXCM Comparison
Compare DGX & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DGX | DXCM |
|---|---|---|
| Founded | 1967 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 26.5B |
| IPO Year | 1996 | 2005 |
Fundamental Metrics
Financial Performance| Metric | DGX | DXCM |
|---|---|---|
| Price | $195.15 | $62.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 21 |
| Target Price | ★ $208.62 | $85.33 |
| AVG Volume (30 Days) | 622.7K | ★ 3.2M |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.74% | N/A |
| EPS Growth | 13.78 | ★ 47.18 |
| EPS | ★ 8.75 | 2.09 |
| Revenue | ★ $11,035,000,000.00 | N/A |
| Revenue This Year | $7.53 | $14.48 |
| Revenue Next Year | $3.77 | $12.39 |
| P/E Ratio | ★ $22.59 | $31.65 |
| Revenue Growth | ★ 11.78 | N/A |
| 52 Week Low | $157.20 | $54.11 |
| 52 Week High | $213.50 | $89.07 |
Technical Indicators
Market Signals| Indicator | DGX | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 42.19 | 29.53 |
| Support Level | $194.77 | $54.11 |
| Resistance Level | $197.55 | $69.18 |
| Average True Range (ATR) | 4.18 | 1.94 |
| MACD | -0.81 | -0.30 |
| Stochastic Oscillator | 18.14 | 1.06 |
Price Performance
Historical ComparisonAbout DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.